Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma

被引：0
|
作者：
Kurban, Ghada [1 ]
Tsavachidou, Dimitra [2 ]
Gallie, Brenda [1 ]
Evans, Andrew [1 ]
Fineii, Antonio [1 ]
Jonasch, Eric [2 ]
Jewett, Michael [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1278
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1278
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Proteomic signatures of clear cell renal cell carcinoma
    Chad J. Creighton
    Nature Reviews Nephrology, 2020, 16 : 133 - 134
  • [2] Proteomic signatures of clear cell renal cell carcinoma
    Creighton, Chad J.
    NATURE REVIEWS NEPHROLOGY, 2020, 16 (03) : 133 - 134
  • [3] Reduced Natural Killer Cell Subsets in Perinatally Acquired Long-Term Non-Progressor Human Immunodeficiency Virus-Infected Children
    Bhukkar, Ravinder
    Sachdeva, Ravinder Kaur
    Suri, Deepti
    Shandilya, Jitendra
    Rawat, Amit
    Saikia, Biman
    Singh, Surjit
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (05) : 437 - 443
  • [4] Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
    Steffen Durinck
    Eric W Stawiski
    Andrea Pavía-Jiménez
    Zora Modrusan
    Payal Kapur
    Bijay S Jaiswal
    Na Zhang
    Vanina Toffessi-Tcheuyap
    Thong T Nguyen
    Kanika Bajaj Pahuja
    Ying-Jiun Chen
    Sadia Saleem
    Subhra Chaudhuri
    Sherry Heldens
    Marlena Jackson
    Samuel Peña-Llopis
    Joseph Guillory
    Karen Toy
    Connie Ha
    Corissa J Harris
    Eboni Holloman
    Haley M Hill
    Jeremy Stinson
    Celina Sanchez Rivers
    Vasantharajan Janakiraman
    Weiru Wang
    Lisa N Kinch
    Nick V Grishin
    Peter M Haverty
    Bernard Chow
    Julian S Gehring
    Jens Reeder
    Gregoire Pau
    Thomas D Wu
    Vitaly Margulis
    Yair Lotan
    Arthur Sagalowsky
    Ivan Pedrosa
    Frederic J de Sauvage
    James Brugarolas
    Somasekar Seshagiri
    Nature Genetics, 2015, 47 : 13 - 21
  • [5] Spectrum of diverse genomic alterations define non-clear cell renal carcinoma
    Durinck, Steffen
    Stawiski, Eric W.
    Pavia-Jimenez, Andrea
    Modrusan, Zora
    Kapur, Payal
    Jaiswal, Bijay S.
    Zhang, Na
    Toffessi-Tcheuyap, Vanina
    Nguyen, Thong T.
    Pahuja, Kanika Bajaj
    Chen, Ying-Jiun
    Saleem, Sadia
    Chaudhuri, Subhra
    Heldens, Sherry
    Jackson, Marlena
    Pena-Llopis, Samuel
    Guillory, Joseph
    Toy, Karen
    Ha, Connie
    Harris, Corissa J.
    Holloman, Eboni
    Hill, Haley M.
    Stinson, Jeremy
    Rivers, Celina Sanchez
    Janakiraman, Vasantharajan
    Wang, Weiru
    Kinch, Lisa N.
    Grishin, Nick V.
    Haverty, Peter M.
    Chow, Bernard
    Gehring, Julian S.
    Reeder, Jens
    Pau, Gregoire
    Wu, Thomas D.
    Margulis, Vitaly
    Lotan, Yair
    Sagalowsky, Arthur
    Pedrosa, Ivan
    de Sauvage, Frederic J.
    Brugarolas, James
    Seshagiri, Somasekar
    NATURE GENETICS, 2015, 47 (01) : 13 - +
  • [6] Non-clear cell renal cell carcinoma
    Ahrens, Marit
    Bergmann, Lothar
    UROLOGIE, 2024, 63 (12): : 1240 - 1245
  • [7] Non-Clear Cell Renal Cell Carcinoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 8 - 10
  • [8] A long-term non-progressor with sickle cell disease and heterozygous mutation for CKR-5 δ-32 chemokine receptor mutation.
    Scott, D
    Harrington, T
    BLOOD, 2000, 96 (11) : 37B - 37B
  • [9] Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
    Vermassen, T.
    De Meulenaere, A.
    Van de Walle, M.
    Rottey, Sylvie
    ACTA CLINICA BELGICA, 2017, 72 (01) : 12 - 18
  • [10] Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma
    Yang, Juan
    Yang, Jin
    Gao, Yan
    Zhao, Lingyu
    Liu, Liying
    Qin, Yannan
    Wang, Xiaofei
    Song, Tusheng
    Huang, Chen
    PLOS ONE, 2014, 9 (11):
12345